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Introduction: This case report describes apexogenesis treatment of three molar
teeth of an 8-year-old boy using three different pulpotomy agents. Methods:
Pulpotomy was performed on decayed immature molar teeth with established
irreversible pulpitis and the remaining pulp was capped with either zinc oxide
eugenol, ProRoot mineral trioxide aggregate or calcium-enriched mixture
(CEM) cement. Teeth were restored with stainless steel crowns. Results:
Eighteen months clinical and radiographic follow-up revealed successful
preservation of pulpal vitality with continued root development in all treated
teeth. Conclusion: Based on this case report, CEM cement may be an alternative
option for pulpotomy treatment of immature permanent molars.
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he objective of vital pulp therapy (VPT) is to preserve
and maintain healthy pulp tissue that has been
compromised by trauma, caries, or restorative
procedures. This is essential in young adults who have teeth
with incomplete root development. The preservation of
radicular pulp tissue in these teeth allows continuing apical
maturation[1].
Materials investigated in VPT include calcium hydroxide,
formocresol, zinc oxide eugenol (ZOE), mineral trioxide
aggregate (MTA) and calcium enriched mixture (CEM)
cement. ZOE is an antimicrobial agent and a nontoxic material
for pulp cells with good working and setting time [2, 3]. This
material does not cause diffuse calcification of canals. Mineral
trioxide aggregate has many favorable characteristics that
make it a suitable material for VPT. The physicochemical
properties of MTA allow it to set in the presence of blood or
moisture [4]. It has a favorable biocompatibility [5-7] and
good marginal adaptation [4, 8, 9]. MTA also induces hard
tissue formation [10, 11]. However, MTA is expensive and has
poor handling characteristics, a long setting time and no
predictable antimicrobial activity [12, 13].
Calcium enriched mixture (CEM) cement has clinical
applications similar to MTA. The biological response of
pulpal and periodontal tissues to CEM cement and its sealing
ability are comparable with MTA [14-16]. CEM can set in an
aqueous environment [17]; it has a shorter setting time and
better handling characteristics than MTA [17]. CEM has
demonstrated to manage root resorption and stimulate
dentinal bridge formation [17, 18].
This case report describes the clinical and radiographic
outcomes of pulpotomy using ZOE, MTA and CEM cement
for three immature permanent molars in a single patient.
Case Report
An 8-year-old boy was referred to the department of
Endodontics of Mashhad Faculty of Dentistry with a chief
complaint of pain during chewing and a history of surgery to
correct a cleft palate. There were no problems in the patient’s
medical history. Dental examination revealed the first upper
permanent molars and first right lower permanent molar had
large carious lesions. The involved teeth responded to vitality
test with severe lingering pain and were asymptomatic to
percussion and palpation. Radiographic examination showed
immature apices with no apical lesion (Figures 1A, 2A, 3A,
4A). Based on the clinical/radiographic assessment and severe
coronal breakdown, a treatment of coronal pulpotomies for
the affected molars was chosen. Under local anesthesia with
2% lidocaine and 1:80,000 epinephrine and rubber dam
T
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Figure 1. First right mandibular permanent molar periapical radiograph (ZOE case); A) Initial radiograph; B) Postoperative radiograph; C)
Seven months recall with SS crown; D) 18 months recall
Figure 2. First right maxillary permanent molar periapical radiograph (MTA case); A) Initial radiograph; B) Postoperative radiograph; C) Seven
months recall with SS crown, D) 18 months recall
isolation, the caries of the first right mandibular molar were
excavated. Coronal pulp was removed with a high-speed
sterile round diamond bur (Maillefer, Tulsa, OK, USA) with
water cooling. Hemorrhage was controlled with sterile cotton
pellets and 5.25% NaOCl. Zinc oxide powder plus eugenol
(Kemdent, SwinDon, HT, UK) was placed on the exposed
pulp (Fig 1b) and the cavity was sealed temporarily with
Cavit (Asia Chemi Teb Co., Tehran, Iran). The same
procedure was performed for the first upper molars. In the
right upper molar, MTA powder (ProRoot MTA; Dentsply,
Tulsa Dental, Tulsa, OK, USA) was mixed with distilled
water and placed gently over the exposed pulps (Figure 2B).
A moist cotton pellet was placed on the MTA and the cavity
was sealed temporarily with Cavit. For the first left upper
molar, a 2 mm layer of CEM cement (BioniqueDent, Tehran,
Iran) was placed over the exposed pulp using an amalgam
carrier and was gently adapted to the dentinal walls of the
access cavity with a dry cotton pellet (Figure 3B). A
moistened cotton pellet was placed lightly over it. The tooth
was temporarily filled with Cavit. The patient was re-
examined after 3 days. The teeth were asymptomatic and
permanent restorations were completed. Because of the
large decay and low remaining dental tissue, we decided to
restore the teeth with a stainless steel (SS) crown (Figures
1C, 2C, 3C). The first left molar also had a carious lesion
but responded normally to all vitality tests and was restored
with amalgam (Figure 4A).
The 6-, 12- and 18-month follow-up revealed no
clinical problems in all treated teeth and periapical
radiographs showed that the apices were closed with no
sign of pathology (Figures 1D, 2D, 3D, 4B). However, after
18 months, slight widening of PDL was seen in the first
right mandibular molar treated using ZOE that needs
longer follow-up period.
Discussion
Dental caries can result in irreversible pulpal damage finally
causing loss of pulpal vitality in immature teeth, impeding
tooth development [19]. Abnormal root development has
been suggested to impact long-term tooth retention [20,
21]. Thus, the primary goal in treating immature teeth is to
maintain pulp vitality so that apexogenesis can occur [22,
23]. The most reliable prognostic indicator for success of
VPT in immature permanent teeth is radiographic
confirmation of root development as well as root-end
closure [1].
In the case presented here, the first right lower molar
was pulpotomized with ZOE and crowned with SS crown
but the contralateral tooth was restored with amalgam.
After one year, the pulpotomized molar showed successful
clinical and radiographic root development and therefore
outcomes. Interestingly, it had accelerated root
development compared to the contralateral tooth. In some
cases root canal therapy is necessary after apex closure due
to restorative demands. According to reliable treatment
outcome in short-term evaluation and low probability of
canal orifice calcification after ZOE pulpotomy, its use in
these situations can be recommended.
Formocresol and ZOE are commonly used for
pulpotomy of primary teeth, with a demonstrated acceptable
success rate [24, 25]. It is compared the success rate of using
MTA and ZOE as vital pulpotomy agents in immature
permanent teeth, here. Researchers found that both ZOE and
MTA treatments had clinical and radiographic success in
immature permanent teeth; although MTA was more
successful [26]. In the patient presented here, after 18 months
slight widening of PDL was seen in tooth treated with ZOE,
however the patient had no clinical symptoms.
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Figure 3. First left maxillary molar (CEM case); A) Initial radiograph; B) Postoperative radiograph; C) Seven months recall with SS Crown;
D) 18 months recall
Figure 4. A) Panoramic tomography of the first left mandibular molar with no pulp exposure which has been restored; B) 18 months recall
For permanent teeth, calcium hydroxide has been the
material of choice used in VPT for many years [27]. Despite its
apparent success in VPT, Ca(OH)2 has been shown to be toxic
to cells in tissue culture and is caustic to vital pulp tissue [28].
Therefore, an ideal VPT material should be biocompatible and
stimulates dentin formation and apical development of
immature teeth. MTA provides a non-resorbable seal over the
vital pulp [6, 29]. Accorinte et al. reported that pulp healing
with MTA is faster than with Ca(OH)2 [30]. Previous
investigations showed favorable outcomes in human teeth with
MTA pulpotomy treatment [31, 32].
The sealing ability of CEM cement is similar to MTA and
the two materials have comparable biocompatibilities when
used as pulp covering agents [14, 33]. In this case report, upper
molars treated with MTA and CEM demonstrated comparable
successful results. The use of CEM cement for pulpotomy of
mature/immature molars has shown good results [33-37].
Recently, Nosrat et al. compared adiographic outcomes of
pulpotomy treatment using CEM and MTA in carious-
exposed vital immature molars [36]. They reported complete
apical closure in 76.8% of the CEM group and 73.8% of the
MTA group, with no significant difference between groups.
MTA and CEM cement appear to have the required
properties for VPT material. The clinical application of CEM
cement for apexogenesis of roots may be an appropriate
treatment choice. However, further clinical studies with
longer follow-up periods are necessary.
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